Skip to main content

Table 6 Patient-related outcomes pre- and post-intervention

From: Feasibility and cost description of highly intensive rehabilitation involving new technologies in patients with post-acute stroke—a trial of the Swiss RehabTech Initiative

 

Pre-intervention

Post-intervention

Median change [95% CI]

p (α = 0.05)

r [95% CI]

Lower extremity, gait, and balance

 10MWT (in seconds) comfortable (N = 12)

28.6 [22.9]

19.0 [19.6]

− 1.75 [− 8.4 to − 0.6]

0.014

0.738 [0.38–0.89]

 10MWT (in seconds) maximum (N = 12)

21.6 [23.4]

15.1 [19.3]

− 1.25 [− 9.5 to − 0.9]

0.016

0.679 [0.29–0.89]

 CSMA-WI, walking capacity

16 [8.3]

19 (7.8)

2 [0.0–3.5]

NS

 BBS, balance abilities

32 [24]

39 [18.8]

5.5 [2.0–9.0]

0.001

0.88 [0.88–0.89]

 FAC, mobility status

2 [2]

3.5 (3)

0.5 [0.0–1.0]

0.015

0.703 [0.46–0.86]

Upper extremity

 FMA-UE, upper extremity motor function

16 [12.5]

27.5 [23.8]

8 [3.0–12.0]

0.002

0.87 [0.84–0.91]

 BBT, gross manual dexterity (affected side)

0 [19.8]

1 [30.8]

1 [0.0–8.0]

0.014

0.74 [0.53–0.86]

Generic outcome measures

 SIS, stroke impact (64–320)

219 [39.8]

238 [38]

13 [0.0–39.0]

0.003

0.78 [0.54–0.88]

 SIS, stroke recovery (0–100%)

50 [35]

65.5 [17.5]

7.5 [− 5.0 to 30.0]

NS

 FIM, generic functional performance

102 [47.5]

104.5 [32.5]

5.0 [1.0–13.0]

0.002

0.86 [0.78–0.89]

 EQ-5D Index

0.7 [0.16]

0.8 [0.14]

0.09 [0.0–0.1]

NS

  1. Sampling units: N = 14; CI confidence interval, P p-value provided by Wilcoxon signed-rank test, NS non-significant, r effect size r, calculated as z statistic extracted from a paired-sample Wilcoxon signed-rank test, divided by square root of the sample size, 10MWT 10 Meter Walking Test, CSMA-WI Chedoke-McMaster Stroke Assessment – Walking Index, BBS Berg Balance Scale, FAC Functional Ambulation Category, FMA-UE Fugl-Meyer Assessment -Upper Extremity, BBT Box&Block Test, SIS Stroke Impact Scale, FIM Functional Independence Measure